Healthcare - Biotechnology - NASDAQ - US
$ 25.7
1.3 %
$ 15.1 B
Market Cap
10.12
P/E
BALANCE SHEET
16.4 B
ASSETS
6.3 B
LIABILITIES
6.53 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Royalty Pharma plc
| Current Assets | 1.27 B |
| Cash & Short-Term Investments | 495 M |
| Receivables | 775 M |
| Other Current Assets | 3.8 M |
| Non-Current Assets | 15.1 B |
| Long-Term Investments | 1.01 B |
| PP&E | 0 |
| Other Non-Current Assets | 14.1 B |
| Current Liabilities | 161 M |
| Accounts Payable | 15.2 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 146 M |
| Non-Current Liabilities | 6.14 B |
| Long-Term Debt | 6.14 B |
| Other Non-Current Liabilities | 900 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 477.0 | 1 710.8 | 1 541.0 | 1 009.0 | 283.7 | 1 924.2 | 1 381.6 | 1 674.2 | 1 720.9 |
| Short Term Investments | 18.3 | 717.0 | 1 262.2 | 983.0 | 509.5 | 461.8 | 0 | 0 | 0 |
| Receivables | 775.1 | 727.9 | 682.7 | 626.4 | 491.3 | 660.4 | 0 | 0 | 0 |
| Inventory | 0 | 1 | 1 | 657.1 | 0 | 19.2 | 0 | 0 | 0 |
| Other Current Assets | 3.8 | 90.5 | 6.6 | 8.6 | 92 K | (14.5) | 1 566.1 | 1 329.9 | 1 323.0 |
| Total Current Assets | 1 274.2 | 2 554.9 | 2 878.2 | 2 696.9 | 832.1 | 2 608.6 | 2 947.7 | 3 004.1 | 3 043.9 |
| PP&E | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.8 | 14.5 | 5.7 | 28.7 | 51.7 | 75.6 | 0 | 0 | 6 949.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 1 012.5 | 14 228.9 | 14 627.8 | 13 266.1 | 11 478.1 | 8 666.8 | 0 | 0 | 0 |
| Other Long Term Assets | 14 093.4 | 15.1 | 4.1 | 28.6 | 88.0 | 19.1 | 0 | 0 | 822.3 |
| Other Assets | 0 | 0 | 0 | 5 076.8 | 0 | 0 | 0 | 1 | 0.000001 |
| Total Assets | 16 381.9 | 16 813.5 | 17 515.9 | 21 097.0 | 12 449.9 | 11 370.1 | 11 373.5 | 10 482.0 | 10 815.7 |
| LIABILITIES | |||||||||
| Accounts Payable | 15.2 | 7.9 | 5.6 | 10.8 | 11.2 | 4.5 | 0 | 0 | 0 |
| Short Term Debt | 0 | 997.5 | 0 | 0 | 282.0 | 281.4 | 280.9 | 172.7 | 184.4 |
| Other Current Liabilities | 146.2 | 161.4 | 165.6 | 297.1 | 40.3 | 294.3 | 102.5 | 124.6 | 130.0 |
| Total Current Liabilities | 161.4 | 1 166.8 | 171.2 | 307.9 | 333.4 | 580.2 | 383.4 | 297.3 | 314.4 |
| Long Term Debt | 6 135.3 | 6 118.8 | 7 096.1 | 5 816.6 | 5 956.1 | 6 237.9 | 6 520.9 | 5 724.7 | 5 804.2 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.9 | 2.5 | 0 | 0 | 18.9 | 0 | 0 | 0 | 0 |
| Total Liabilities | 6 297.6 | 7 288.1 | 7 267.3 | 6 124.0 | 6 308.5 | 6 818.1 | 6 904.3 | 6 022.0 | 6 118.6 |
| EQUITY | |||||||||
| Common Stock | 45 K | 0.1 | 0.1 | 0.1 | 3 282.5 | 3 282.5 | 0 | 0 | 0 |
| Retained Earnings | 2 517.6 | 1 964.7 | 2 255.2 | 1 920.6 | 2 825.2 | 1 216.0 | 0 | 0 | 0 |
| Other Accumulative Comprehensive Income/Loss | 63 K | 63 K | 16.5 | 34.4 | 2.1 | (10.3) | 0 | 0 | 0 |
| Total Equity | 10 084.3 | 9 525.4 | 10 248.5 | 14 973.0 | 6 141.4 | 4 552.1 | 4 460.5 | 4 445.6 | 4 676.9 |
| Total Liabilities and Equity | 16 381.9 | 16 813.5 | 17 515.9 | 21 097.0 | 12 449.9 | 11 370.1 | 11 364.8 | 10 467.6 | 10 795.5 |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 447.6 | 438.0 | 414.8 | 375.4 | 365.9 | 354.2 | 354.2 | 607.0 | 607.0 |